Endpoint at 3 months | |||
---|---|---|---|
CR (n = 29) | Failure/death (n = 17) | p | |
Clinical factors | |||
Age | 64.0 (59.6 to 68.3) | 59.4 (53.9 to 64.9) | 0.18 |
F/M | 3/26 | 1/16 | 1.0 |
T2/T3/T4 | 2/27/0 | 4/8/5 | 0.001 |
1/2-site T | 28/1 | 13/4 | 0.055 |
N0/N1 | 22/7 | 8/9 | 0.048 |
FDG-PET/CT parameters | |||
SUVmax1 | 12.5 (10.8 to 14.2) | 15.4 (10.9 to 20.0) | 0.44 |
TV1 | 9.7 (7.2 to 13.1) | 20.6 (13.2 to 32.2) | 0.004 |
SUVmax2 | 7.1 (5.9 to 8.2) | 8.6 (6.4 to 10.9) | 0.23 |
TV2 | 4.8 (3.3 to 6.9) | 11.1 (4.6 to 13.6) | 0.009 |
V g | 3.1 (1.8 to 5.1) | 5.8 (3.5 to 9.8) | 0.056 |
V r | 5.6 (4.0 to 7.9) | 9.8 (6.2 to 15.5) | 0.047 |